Related Experiment Video
Updated: Jun 6, 2026
07:40
A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation
Published on: August 30, 2019
[Pro-resolving lipid mediators in inflammatory lung diseases].
O Eickmeier1, J N Hilberath, S Zielen
1Zentrum für Kinder- und Jugendmedizin, Allergologie, Pneumologie und Mukoviszidose, Klinikum der Johann Wolfgang Goethe- Universität Frankfurt a.M. olaf.eickmeier@kgu.de
Pneumologie (Stuttgart, Germany)
|December 1, 2010
Summary
New lipid mediators like lipoxins, resolvins, protectins, and maresins show potent anti-inflammatory effects in lung inflammation models. These compounds derived from polyunsaturated fatty acids offer therapeutic potential for lung diseases.
Area of Science:
- Biochemistry
- Immunology
- Pharmacology
Context:
- Uncontrolled lung inflammation poses a significant healthcare burden.
- Current therapeutic options for pathological lung inflammation are limited.
- Novel anti-inflammatory and pro-resolving lipid mediators have been identified.
Purpose:
- To explore the therapeutic potential of newly identified lipid mediators in treating lung inflammation.
- To investigate the anti-inflammatory effects of specific lipid mediators derived from polyunsaturated fatty acids.
Summary:
- Lipoxins, resolvins, protectins, and maresins are novel lipid mediators derived from arachidonic acid (AA), docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA).
- These mediators exhibit potent anti-inflammatory and pro-resolving actions.
- In vitro and in vivo studies in murine models demonstrate their efficacy in reducing lung inflammation.
Impact:
- These lipid mediators represent a promising new class of therapeutics for inflammatory lung diseases.
- Potential applications include treatment for asthma, cystic fibrosis, and acute lung injury.
- Further research could lead to novel strategies for managing chronic and acute respiratory conditions.
Related Concept Videos
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:28Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...